- Home
- BMEZ
as 11-15-2024 4:00pm EST
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 1.7B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 391.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | 0.54 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.93 - $16.95 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of BlackRock Health Sciences Term Trust of Beneficial Interest (BMEZ)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Oct 15 '24 | Buy | $15.81 | 64,716 | $1,023,159.96 | 20,750,913 | |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Oct 14 '24 | Buy | $15.87 | 15,281 | $242,509.47 | 20,750,913 | |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Oct 1 '24 | Buy | $15.79 | 9,526 | $150,415.54 | 20,750,913 | |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Sep 30 '24 | Buy | $15.84 | 8,012 | $126,910.08 | 20,750,913 | |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Sep 26 '24 | Buy | $15.85 | 49,504 | $782,788.88 | 20,750,913 | |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Sep 25 '24 | Buy | $15.73 | 300 | $4,719.00 | 20,750,913 | |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Sep 23 '24 | Buy | $15.98 | 2,006 | $32,055.88 | 20,750,913 | |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Sep 19 '24 | Buy | $16.14 | 15,455 | $249,443.70 | 20,750,913 | |
| Saba Capital Management, L.P. | BMEZ | 10% Owner | Sep 17 '24 | Buy | $15.91 | 47,682 | $758,547.56 | 20,750,913 |
Latest BlackRock Health Sciences Term Trust of Beneficial Interest News
BMEZ Breaking Stock News: Dive into BMEZ Ticker-Specific Updates for Smart Investing
Business Wire
2 months ago
Distribution Dates and Amounts Announced for ECAT, BCAT, BMEZ, BSTZ and BIGZ
Business Wire
3 months ago
Certain BlackRock Funds Announce Final Results of Tender Offers
Business Wire
3 months ago
Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers
Business Wire
5 months ago
Saba Capital Corrects BlackRock’s Intentionally False and Misleading 2024 Annual Meeting Results
Business Wire
5 months ago
ISS Endorses ALL of Saba Capital’s Nominees at the BlackRock Science and Technology Term Trust and BlackRock California Municipal Income Trust
GuruFocus.com
5 months ago
A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
Energy Global
5 months ago
ANDRITZ to equip new Silvan hydropower plant in Türkiye
USA TODAY
5 months ago
Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
Compare BMEZ vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BMEZ BlackRock Health Sciences Term Trust of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.